Drugs / AZD6918
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00733031 | Aug 2008 → Mar 2009 | cancer | AstraZeneca | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD6918 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00733031 ↗ |
| Route | Oral | “liquid suspension, daily, oral dose” NCT00733031 ↗ |